Abstract
This study was aimed to determine the effects of quercetin on the interleukin-1β (IL-1β)-induced proliferation of rheumatoid synovial fibroblasts (RASFs) and production of matrix metalloproteinases (MMPs), cyclooxygenase (COX), and prostaglandin E2 (PGE2) by RASFs. The proliferation and apoptosis of RASFs was evaluated with CCK-8 reagent and flow cytometry in the presence of IL-1with CCK-8 reagquercetin. The expression of MMPs, IL-1β enhanced the expression of MMP-1, MMP-3, tissue inhibitor of metalloproteinase (TIMP)-1, COXs, PGE2, and intracellular mitogen-activated protein kinase (MAPK) signalings including phosphorylated extracellular signal-regulated kinase (p-ERK), p-p38, phosphorylated c-Jun N-terminal kinase (p-JNK), and nuclear factor kB (NF-kB) were examined by immunoblotting or semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) in conditions as described above. Quercetin inhibits unstimulated and IL-1β-induced proliferation of RASFs and MMP-1, 3, COX-2 messenger ribonucleic acid and protein expression, PGE2 production induced with IL-1β. Quercetin also inhibits the phosphorylation of ERK-1/2, p38, JNK and activation of NF-kB by IL-1ed. These results indicate that quercetin inhibits synovial fibroblasts proliferation and MMPs, COX-2, and PGE2 production, which involved joint destruction in rheumatoid arthritis (RA), and suggest that it might be a new therapeutic agent for management of RA.
Similar content being viewed by others
REFERENCES
Cawston, T.E. 1995. Proteinase and connective tissue breakdown. In Mechanisms and models in rheumatoid arthritis, ed. B. Henderson, J.C.W. Edwards, and E.R. Pettipher. London: Academic Press.
Han, M.K., J.S. Kim, B.H. Park, et al. 2003. NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: Potential role in rheumatoid arthritis. Journal of Leukocyte Biology 73: 525–529.
Firestein, G.S. 1997. Etiology and pathogenesis of rheumatoid arthritis. In Textbook of rheumatology, 5th ed, ed. W.N. Kelley, E.D. Harris Jr., S. Ruddy, and C.B. Sledge, 851–897. Philadelphia: WB Saunders.
Choy, E.H., and G.S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. The New England Journal of Medicine 344: 907–916.
Cho, E.J., T. Yokozawa, D.Y. Rhyu, H.Y. Kim, N. Shibahara, and J.C. Park. 2003. The inhibitory effects of 12 medicinal plants and their component compounds on lipid peroxidation. The American Journal of Chinese Medicine 31: 907–917.
Kang, D.G., T.Y. Hur, G.M. Lee, H. Oh, T.O. Kwon, E.J. Sohn, and H.S. Lee. 2002. Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension. Life Sciences 70: 2599–2609.
Chang, S.H., E.J. Jung, D.G. Lim, B. Oyungerel, K.I. Lim, E. Her, W.S. Choi, M.H. Jun, K.D. Choi, D.J. Han, and S.C. Kim. 2008. Anti-inflammatory action of Cudrania tricuspidata on spleen cell and T lymphocyte proliferation. Journal of Pharmacy and Pharmacology 60: 1221–1226.
Seo, W.G., H.O. Pae, G.S. Oh, K.Y. Chai, Y.G. Yun, H.T. Chung, K.K. Jang, and T.O. Kwon. 2001. Ethyl acetate extract of the stem bark of Cudrania tricuspidata induces apoptosis in human leukemia HL-60 cells. The American Journal of Chinese Medicine 29: 313–320.
Lee, E.G., S.L. Lee, H.J. Chae, S.J. Park, Y.C. Lee, and W.H. Yoo. 2010. Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production. Biological Research 43: 225–231.
Guardia, T., A.E. Rotelli, A.O. Juarez, and L.E. Pelzer. 2001. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 56: 683–687.
Jackson, J.K., T. Higo, W.L. Hunter, and H.M. Burt. 2006. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflammation Research 55: 168–175.
Comalada, M., D. Camuesco, S. Sierra, I. Ballester, J. Xaus, J. Gálvez, and A. Zarzuelo. 2006. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. European Journal of Immunology 35: 584–592.
Kumazawa, Y., K. Kawaguchi, and H. Takimoto. 2006. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Current Pharmaceutical Design 12: 4271–4279.
Mamani-Matsuda, M., T. Kauss, A. Al-Kharrat, J. Rambert, F. Fawaz, D. Thiolat, D. Moynet, S. Coves, D. Malvy, and M.D. Mossalayi. 2006. Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochemical Pharmacology 72: 1304–1310.
Ruiz, P.A., A. Braune, G. Holzlwimmer, L. Quintanilla-Fend, and D. Haller. 2007. Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. Journal of Nutrition 137: 1208–1215.
Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, and H.S. Luthra. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.
Lee, H.Y., H.S. Jeon, E.K. Song, M.K. Han, S.I. Park, S.I. Lee, H.J. Yun, J.R. Kim, J.S. Kim, Y.C. Lee, S.I. Kim, H.R. Kim, J.Y. Choi, I. Kang, H.Y. Kim, and W.H. Yoo. 2006. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Arthritis and Rheumatism 54: 1747–1758.
Hodgkin, P.D., L.C. Yamashita, R.L. Coffman, and M.R. Kehry. 1990. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. Journal of Immunology 145: 2025–2034.
Guan, Y., Z. Yin, L. Guo, X. Huang, W. Ye, and W. Shen. 2009. Studies on chemical constituents from stems of Cudrania tricuspidata. Zhongguo Zhongyao Zazhi 34: 1108–1110.
Yu, E.S., H.J. Min, S.Y. An, H.Y. Won, J.H. Hong, and E.S. Hwang. 2008. Regulatory mechanisms of IL-2 and IFNgamma suppression by quercetin in T helper cells. Biochemical Pharmacology 76: 70–78.
Gitter, B.D., J.M. Labus, S.L. Lees, and M.E. Scheetz. 1989. Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha. Immunology 66: 196–200.
Crofford, L.J., R.L. Wilder, A.P. Ristimaki, H. Sano, E.F. Remmers, H.R. Epps, and T. Hla. 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. Journal of Clinical Investigation 93: 1095–1101.
Tolboom, T.C., E. Pieterman, W.H. van der Laan, R.E. Toes, A.L. Huidekoper, R.G. Nelissen, F.C. Breedveld, and T.W. Huizinga. 2002. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Annals of the Rheumatic Diseases 61: 975–980.
Martel-Pelletier, J., J.P. Pelletier, and H. Fahmi. 2004. New insights into prostaglandin biology. Journal of Rheumatology 31: 14–16.
Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes & Development 9: 2723–2735.
Han, Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning, and G.S. Firestein. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. Journal of Clinical Investigation 108: 73–81.
Guan, Z., L.D. Baier, and A.R. Morrison. 1997. p38 mitogen-activated protein kinase downregulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta. Journal of Biological Chemistry 272: 8083–8089.
Lasa, M., M. Brook, J. Saklatvala, and A.R. Clark. 2001. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Molecular and Cellular Biology 21: 771–780.
McIntyre, K.W., D.J. Shuster, K.M. Gillooly, D.M. Dambach, M.A. Pattoli, P. Lu, X.D. Zhou, Y. Qiu, F.C. Zusi, and J.R. Burke. 2003. A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis and Rheumatism 48: 2652–2659.
Nishikawa, M., A. Myoui, T. Tomita, K. Takahi, A. Nampei, and H. Yoshikawa. 2003. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis and Rheumatism 48: 2670–2681.
Min, Y.D., C.H. Choi, H. Bark, H.Y. Son, H.H. Park, S. Lee, J.W. Park, E.K. Park, H.I. Shin, and S.H. Kim. 2007. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflammation Research 56: 210–215.
Sato, M., T. Miyazaki, F. Kambe, K. Maeda, and H. Seo. 1997. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. Journal of Rheumatology 24: 1680–1684.
ACKNOWLEDGMENTS
This study was supported by a grant of the Korea Healthcare Technology R&D Project, the Ministry for Health, Welfare, and Family Affairs, Republic of Korea (A084144).
Conflicts of Interest
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Myung-Soon Sung and Eun-Gyeong Lee contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sung, MS., Lee, EG., Jeon, HS. et al. Quercetin Inhibits IL-1β-Induced Proliferation and Production of MMPs, COX-2, and PGE2 by Rheumatoid Synovial Fibroblast. Inflammation 35, 1585–1594 (2012). https://doi.org/10.1007/s10753-012-9473-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-012-9473-2